276 related articles for article (PubMed ID: 27567805)
1. Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.
Martire S; Fuso A; Mosca L; Forte E; Correani V; Fontana M; Scarpa S; Maras B; d'Erme M
J Alzheimers Dis; 2016 Aug; 54(1):307-24. PubMed ID: 27567805
[TBL] [Abstract][Full Text] [Related]
2. Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.
Abeti R; Abramov AY; Duchen MR
Brain; 2011 Jun; 134(Pt 6):1658-72. PubMed ID: 21616968
[TBL] [Abstract][Full Text] [Related]
3. beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease.
Arias C; Montiel T; Quiroz-Báez R; Massieu L
Exp Neurol; 2002 Jul; 176(1):163-74. PubMed ID: 12093093
[TBL] [Abstract][Full Text] [Related]
4. MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease.
Pohland M; Pellowska M; Asseburg H; Hagl S; Reutzel M; Joppe A; Berressem D; Eckert SH; Wurglics M; Schubert-Zsilavecz M; Eckert GP
Alzheimers Res Ther; 2018 Feb; 10(1):18. PubMed ID: 29433569
[TBL] [Abstract][Full Text] [Related]
5. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease.
Wang X; Hu X; Yang Y; Takata T; Sakurai T
Exp Neurol; 2015 Sep; 271():145-54. PubMed ID: 26057947
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.
Turunc Bayrakdar E; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
Free Radic Res; 2014 Feb; 48(2):146-58. PubMed ID: 24151909
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for ascorbate.
Dixit S; Fessel JP; Harrison FE
Free Radic Biol Med; 2017 Nov; 112():515-523. PubMed ID: 28863942
[TBL] [Abstract][Full Text] [Related]
8. PARP-1 modulates amyloid beta peptide-induced neuronal damage.
Martire S; Fuso A; Rotili D; Tempera I; Giordano C; De Zottis I; Muzi A; Vernole P; Graziani G; Lococo E; Faraldi M; Maras B; Scarpa S; Mosca L; d'Erme M
PLoS One; 2013; 8(9):e72169. PubMed ID: 24086258
[TBL] [Abstract][Full Text] [Related]
9. Parp mutations protect from mitochondrial toxicity in Alzheimer's disease.
Yu Y; Fedele G; Celardo I; Loh SHY; Martins LM
Cell Death Dis; 2021 Jun; 12(7):651. PubMed ID: 34172715
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease related peptides affected cholinergic receptor mediated poly(ADP-ribose) polymerase activity in the hippocampus.
Adamczyk A; Jeśko H; Strosznajder RP
Folia Neuropathol; 2005; 43(3):139-42. PubMed ID: 16245207
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Evaluation of a Mitochondria-Targeting Poly(ADP-ribose) Polymerase-1 Inhibitor.
Krainz T; Lamade AM; Du L; Maskrey TS; Calderon MJ; Watkins SC; Epperly MW; Greenberger JS; Bayır H; Wipf P; Clark RSB
ACS Chem Biol; 2018 Oct; 13(10):2868-2879. PubMed ID: 30184433
[TBL] [Abstract][Full Text] [Related]
12. Non A beta component of Alzheimer's disease amyloid and amyloid beta peptides evoked poly(ADP-ribose) polymerase-dependent release of apoptosis-inducing factor from rat brain mitochondria.
Adamczyk A; Czapski GA; Jeśko H; Strosznajder RP
J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():5-13. PubMed ID: 16077187
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo protective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with Aβ(1-42).
Bayrakdar ET; Armagan G; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
Cell Biochem Funct; 2014 Oct; 32(7):557-64. PubMed ID: 25111857
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of poly(ADP-ribose) polymerase-1 alters expression of mitochondria-related genes in PC12 cells: relevance to mitochondrial homeostasis in neurodegenerative disorders.
Czapski GA; Cieślik M; Wencel PL; Wójtowicz S; Strosznajder RP; Strosznajder JB
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):281-288. PubMed ID: 29128369
[TBL] [Abstract][Full Text] [Related]
15. Novel antioxidants protect mitochondria from the effects of oligomeric amyloid beta and contribute to the maintenance of epigenome function.
Mastroeni D; Khdour OM; Arce PM; Hecht SM; Coleman PD
ACS Chem Neurosci; 2015 Apr; 6(4):588-98. PubMed ID: 25668062
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease.
Strosznajder JB; Czapski GA; Adamczyk A; Strosznajder RP
Mol Neurobiol; 2012 Aug; 46(1):78-84. PubMed ID: 22430645
[TBL] [Abstract][Full Text] [Related]
17. A cell model for the initial phase of sporadic Alzheimer's disease.
Stockburger C; Gold VA; Pallas T; Kolesova N; Miano D; Leuner K; Müller WE
J Alzheimers Dis; 2014; 42(2):395-411. PubMed ID: 24898661
[TBL] [Abstract][Full Text] [Related]
18. NAD+ as a metabolic link between DNA damage and cell death.
Ying W; Alano CC; Garnier P; Swanson RA
J Neurosci Res; 2005 Jan 1-15; 79(1-2):216-23. PubMed ID: 15562437
[TBL] [Abstract][Full Text] [Related]
19. AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
Bielarczyk H; Jankowska-Kulawy A; Höfling C; Ronowska A; Gul-Hinc S; Roßner S; Schliebs R; Pawelczyk T; Szutowicz A
J Alzheimers Dis; 2015; 48(4):1083-94. PubMed ID: 26402099
[TBL] [Abstract][Full Text] [Related]
20. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease.
Du F; Yu Q; Yan S; Hu G; Lue LF; Walker DG; Wu L; Yan SF; Tieu K; Yan SS
Brain; 2017 Dec; 140(12):3233-3251. PubMed ID: 29077793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
